Investing in PSC Unlocks Tax Benefits
PSC investors benefit from Section 1202 of the Internal Revenue Code which offers a significant tax incentive.
How Epigenetics Shapes the Journey of Aging
Aging is a universal part of life, but have you ever wondered why some people seem to age more gracefully than others? The answer lies hidden within our genes, and a fascinating field of science known as epigenetics is shedding light on this timeless mystery.
Growth Factors: The Benefits and Risks
Growth factors have the potential to be a useful tool in regenerative medicine but more studies are needed to ensure their safe and effective use.
Exosomes Early Promise
While exosome therapy is a burgeoning field, there are currently no FDA approved exosome treatments as more studies are needed to confirm the safety and efficacy of such products.
Expanded Access
Expanded access is an FDA program that under certain conditions allows the use of an investigational new drug (IND) to treat a patient with a serious or life-threatening disease outside of a clinical trial.
Eligibility for Right to Try
The Right to Try Act provides a new channel for eligible patients to request access to investigational drugs outside of their ongoing clinical trial.
Stem Cell Therapy: The Right to Try Act
The Right to Try Act allows patients access to treatments that are in the FDA’s drug approval pipeline but not yet approved.
Stem Cells and Anti-Aging
As the science of aging expands its knowledge of all the changes and challenges of aging, the use of stem cells for anti-aging will become one of the standards of care.
Who Named Mesenchymal Stem Cells?
Over thirty years ago Dr. Arnold Caplan coined the term MSCs and since then there have been thousands of clinical trials involving the use of adult stem cells.
Cellular Interventions: Current and Future Stem Cell Treatments
There are a number of cellular interventions that are currently being studied for the treatment of various diseases.